Epidemiological and Clinical Baseline Characteristics as Predictive Biomarkers of Response to Anti-VEGF Treatment in Patients with Neovascular AMD

Epidemiological and Clinical Baseline Characteristics as Predictive Biomarkers of Response to Anti-VEGF Treatment in Patients with Neovascular AMD

Purpose. To review the current literature investigating patient response to antivascular endothelial growth factor-A (VEGF) therapy in the treatment of neovascular age-related macular degeneration (nAMD) and to identify baseline characteristics that might predict response. Method. A literature searc...

Full description

Bibliographic Details
Main Authors:	Miltiadis K. Tsilimbaris, Maria I. López-Gálvez, Roberto Gallego-Pinazo, Philippe Margaron, George N. Lambrou
Format:	Article
Language:	English
Published:	Hindawi Limited 2016-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2016/4367631

Similar Items

New Therapies of Neovascular AMD—Beyond Anti-VEGFs
by: Praveen Yerramothu
Published: (2018-07-01)

New Therapies of Neovascular AMD beyond Anti-VEGF Injections
by: Greggory M. Gahn, et al.
Published: (2018-03-01)

Different Outcomes of Anti-VEGF Treatment for Neovascular AMD according to Neovascular Sutypes and Baseline Features: 2-Year Real-Life Clinical Outcomes
by: Alessandro Arrigo, et al.
Published: (2021-01-01)

Evaluation of long-term efficacy of intravitreal anti-VEGF therapy in neovascular AMD in clinical practice.
by: Adriana Manuel Reis Silva
Published: (2019)

Anti-VEGF Treatment Strategies for Wet AMD
by: Jaclyn L. Kovach, et al.
Published: (2012-01-01)

THE EVALUATION ATTEMPTS IN ANTI-VEGF THERAPY OF AMD MACULAR EDEMA
by: A. V. Tereshchenko, et al.
Published: (2015-10-01)

Correlation of Baseline Visual Acuity with Outcomes of Treatment with Anti-VEGF in Neovascular Age-Related Macular Degeneration
by: Veluswamy B, et al.
Published: (2020-06-01)

Mechanisms of FH Protection Against Neovascular AMD
by: Céline Borras, et al.
Published: (2020-04-01)

Anti-VEGF medicine with PRP for neovascular glaucoma
by: Yue Deng, et al.
Published: (2018-10-01)

Effects of Smoking on Outcomes of Antivascular Endothelial Growth Factor Therapy in Patients with Neovascular Age-Related Macular Degeneration Smoking and Anti-VEGF Therapy in nAMD
by: Hiroyuki Kamao, et al.
Published: (2018-01-01)

Biomarkers of Myopic Choroidal Neovascularization in Women, Determining the Clinical Course and Response to Anti-VEGF Therapy
by: A. V. Grigorieva, et al.
Published: (2021-06-01)

Application of anti-VEGF agents on the treatment of neovascular glaucoma
by: Qi-Meng Chu, et al.
Published: (2016-01-01)

Safety of anti-VEGF drugs with trabeculectomy for neovascular glaucoma
by: Fei Wang, et al.
Published: (2016-05-01)

Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab
by: Deli Krizova, et al.
Published: (2014-01-01)

Treat and Extend Treatment Interval Patterns with Anti-VEGF Therapy in nAMD Patients
by: Adrian Skelly, et al.
Published: (2019-08-01)

Switch to Aflibercept in the Treatment of Neovascular AMD: long-term results
by: Ana Fernanda da Silva Pinheiro
Published: (2019)

Trends in Real-World Neovascular AMD Treatment Outcomes in the UK
by: Mehta H, et al.
Published: (2020-10-01)

Switch to Aflibercept in the Treatment of Neovascular AMD: Long-Term Results
by: Pedro Neves Cardoso, et al.
Published: (2017-01-01)

PRN Treatment of Neovascular AMD with Cycles of Three Monthly Injections
by: Touka Banaee, et al.
Published: (2021-05-01)

Macular density alterations in myopic choroidal neovascularization and the effect of anti-VEGF on it
by: Jian-Bo Mao, et al.
Published: (2021-08-01)

Efficacy of anti-VEGF combined with compound trabeculectomy in the treatment of neovascular glaucoma
by: Cao-Yu Sun, et al.
Published: (2020-09-01)

Observation on the curative effect of anti-VEGF comprehensive treatment for neovascular glaucoma
by: Xiao-Niu Zhang, et al.
Published: (2020-02-01)

Effects of anti-vegf agents on the ocular neovascular structures in diabetic retinopathyes
by: Manuela Beruica
Published: (2009-06-01)

The Application of OCTA in Assessment of Anti-VEGF Therapy for Idiopathic Choroidal Neovascularization
by: Qin Chen, et al.
Published: (2016-01-01)

Inhibitory Effect of Anti-VEGF Drugs Bevacizumab (Avastin) on Corneal Neovascularization
by: Nien-Ting Lin, et al.
Published: (2008)

Anti-VEGF Drugs Influence Epigenetic Regulation and AMD-Specific Molecular Markers in ARPE-19 Cells
by: Mohamed A. Hamid, et al.
Published: (2021-04-01)

Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD
by: Maria Waizel, et al.
Published: (2017-05-01)

New and Innovative Treatments for Neovascular Age-Related Macular Degeneration (nAMD)
by: Prem Patel, et al.
Published: (2021-05-01)

Posterior lens capsule neovascularization treated with anti-VEGF complicated by phacogenic uveitis
by: Felicia Tai, et al.
Published: (2020-12-01)

Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
by: T. Barth, et al.
Published: (2019-11-01)

Anti-Human VEGF Repebody Effectively Suppresses Choroidal Neovascularization and Vascular Leakage.
by: Da-Eun Hwang, et al.
Published: (2016-01-01)

Recent advance on anti-VEGF treatment of choroidal neovascularization secondary to pathological myopia
by: Xing-Zhao Xu, et al.
Published: (2018-09-01)

Current and Future Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration
by: Kaiser SM, et al.
Published: (2021-09-01)

Principles of anti-VEGF dosing in the treatment of neovascular age-related macular degeneration
by: I. E. Ioshin, et al.
Published: (2019-08-01)

Comparison of the effectiveness of various protocols for the transition to aflibercept with tachyphylaxis for ranibizumab in patients with neovascular AMD
by: A. N. Kulikov, et al.
Published: (2018-11-01)

Effect of COVID-19 Lockdown in Spain on Structural and Functional Outcomes of Neovascular AMD Patients
by: Alicia Valverde-Megías, et al.
Published: (2021-08-01)

High Reflectivity and Low Reflectivity Properties on OCTA Influence the Detection of Macular Neovascularization in AMD
by: Alessandro Arrigo, et al.
Published: (2021-06-01)

Predictive factors of response to anti-VEGF therapy in neovascular age-related macular degeneration
by: Tiago Lima da Quinta Pereira de Sousa
Published: (2019)

Comparison of the effects of subconjunctival and topical anti-VEGF therapy (bevacizumab) on experimental corneal neovascularization
by: Ozdemir Ozdemir, et al.
Published: (2014-08-01)

Analysis of intravitreal using of anti vegf-medications for diseases of fundus accompanied by exudation and neovascularization
by: N. G. Zavgorodnya, et al.
Published: (2013-08-01)